Cardioprotective effects of NIP-121, a novel ATP-sensitive potassium channel opener, during ischemia and reperfusion in coronary perfused guinea pig myocardium

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 5, 1996, Pages 695-701

  Tanaka, Hikaru ^a   Okazaki, Kohtaro ^a   Shigenobu, Koki ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Glibenclamide; Guinea pigs; Ischemia; K+ Channel opener; Myocardial injury; NIP 121; Reperfusion

Indexed keywords

7,8 DIHYDRO 7 HYDROXY 6,6 DIMETHYL 8 (2 OXO 1 PIPERIDYL) 6H PYRANO[2,3 F][2,1,3]BENZOXADIAZOLE; ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; DRUG EFFICACY; DRUG SCREENING; GUINEA PIG; HEART ARRHYTHMIA; HEART CONTRACTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANIMALS; GLYBURIDE; GUINEA PIGS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; OXADIAZOLES; PIPERIDINES; POTASSIUM CHANNELS;

EID: 0029914897     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199605000-00012     Document Type: Article

References (50)

1. ± channels in cardiac muscle. Nature 1983;305:147-8.
2. ± channels in arterial smooth muscle. Science 1989;245:177-80.
3. ± channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. Proc Natl Acad Sci USA 1988; 85:1312-6.
4. Treherne JM, Ashford MLJ. The regional distribution of sulfonyl-urea binding sites in rat brain. Neuroscience 1991;40:523-31.
5. Quast U, Guillon JM, Cavero I. Cellular pharmacology of potassium channel openers in vascular smooth muscle. Cardiovasc Res 1994;28:805-10.
6. Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 1993;33:597-637.
7. Robertson DW, Steinberg MI. Potassium channel modulators: scientific applications and therapeutic promise. J Med Chem 1990; 33:1529-41.
8. Buckle DR. Prospects for potassium channel activators in the treatment of airways obstruction. Pulm Pharmacol 1993;6:161-9.
9. Billman GE. Role of ATP-sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischemia. Cardiovasc Res 1994;28:762-9.
10. Gross G, Pieper G, Faber NE, Warltier D, Hardman H. Effects of nicorandil on coronary circulation and myocardial ischemia. Am J Cardiol 1989;63:11J-7J.
11. Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glibenclamide. J Pharmacol Exp Ther 1989; 251:98-104.
12. Grover GJ. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J Cardiovasc Res 1994;24(suppl 4):S18-27.
13. Masuda Y, Takeguchi M, Arakawa C, et al. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative. Arch Int Pharmacodyn Ther 1990;304:247-64.
14. Shikada K, Yamamoto A, Tanaka S. NIP-121 and cromakalim, potassium channel openers, preferentially suppress prostanoid-induced contraction of the guinea-pig isolated trachea. Eur J Pharmacol 1991;209:69-73.
15. Yamashita T, Masuda Y, Tanaka S. Inhibitory properties of NIP-121, a potassium channel opener, on high potassium- and norepinephrine-induced contraction and calcium mobilization in the guinea-pig. J Cardiovasc Pharmacol 1995;24:890-5.
16. Yamashita T, Masuda Y, Tanaka S. Potassium channel openers relax A23187-induced nifedipine-resistant contraction of rat aorta. J Cardiovasc Pharmacol 1994;24:914-20.
17. Masuda Y, Arakawa C, Yamashita T, et al. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein. 1991;195:323-31.
18. + channel opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim. J Cardiovasc Pharmacol 1995;26:608-13.
19. Pierce GN, Maddaford TG, Kroeger EA, Cragoe E. Protection by benzamil against dysfunction and damage in rat myocardium after calcium depletion and repletion. Am J Physiol 1990;258:H17-23.
20. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571-81.
21. Matsui S, Tanaka H, Shigenobu K. The effects of anion modification and anion channel blockers on ischemia and reperfusion damages in coronary-perfused guinea-pig myocardium. Jpn J Pharmacol 1995;67(suppl I):121P.
22. Wollenberger A, Ristan O, Scoffa G. Eine eunfache Technik der extremschnelle abkuhlung grosserer Grwebstruke. Pflugers Arch 1960;270:399-408.
23. McDonald TF, MacLeod DP. Anoxia-recovery cycle in ventricular muscle: action potential duration, contractility and ATP content. Pflugers Arch 1971;325:305-22.
24. Reimer KA, Jennings RB. Myocardial ischemia, hypoxia, and infarction. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The heart and cardiovascular system: scientific foundations, vol. 2. New York: Raven Press, 1991:1875-973.
25. Kleber AG, Oetliker H. Cellular aspects of early contractile failure in ischemia. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The heart and cardiovascular system: scientific foundations, vol. 2. New York: Raven Press, 1991:1975-2020.
26. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardia ischemia and infarction. Physiol Rev 1989;69:1049-169.
27. Kleber AG. Resting membrane potential, extracellular potassium activity, and intracellular sodium activity during acute global ischemia in isolated perfused guinea pig hearts. Circ Res 1983;52: 442-50.
28. +, and acidosis on the intracellular sodium activity and resting potential in guinea pig papillary muscle. Circ Res 1986;58:249-56.
29. Gettes LS, Reuter H. Slow recovery from inactivation of inward currents in mammalian myocardial fibers. J Physiol 1974;240: 703-24.
30. Kodama I, Wilde AAM, Janse MJ, Durrer D, Yamada K. Combined effects of hypoxia, hyperkalemia and acidosis on membrane action potential and excitability of guinea-pig ventricular muscle. J Mol Cell Cardiol 1984;16:246-59.
31. Patterson E, Scherlag BJ, Lazzara R. Rapid inward current in ventricular epicardium and epicardial myocytes following myocardial infarction. J Cardiovasc Electrophysiol 1993;4:9-22.
32. Stern MD, Silverman HS, Houser SR, et al. Anoxic contractile failure in rat heart myocytes is caused by failure of intracellular calcium release due to alteration of the action potential. Proc Natl Acad Sci USA 1988;85:6954-8.
33. Lederer WJ, Nichols CG, Smith GL. The mechanism of early contractile failure of isolated rat ventricular myocytes subjected to complete metabolic inhibition. J Physiol 1989;413:329-49.
34. 2+ currents in isolated guinea pig cardiocytes. Pflugers Arch 1990;416:207-9.
35. D'Alonzo AJ, Darbenzio RB, Parham CS, Grover GJ. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc Res 1992;26:1046-53.
36. Elliot AC, Smith GL, Allen DG. Simultaneous measurements of action potential duration and intracellular ATP in isolated ferret hearts exposed to cyanide. Circ Res 1989;64:583-91.
37. + channel activity in intact and permeabilized rat ventricular myocytes. J Physiol 1990;423:91-110.
38. K1 in the myocardial response to hypoxia. Cardiovasc Res 1991;25:17-26.
39. 0 on the membrane potential of rabbit ventricle. J Mol Cell Cardiol 1983;15:845-54.
40. 2+ in single rat heart cells during anoxia and reoxygenation. Biochem J 1987;244:381-5.
41. ATP channels in isolated heart cells of the guinea-pig. J Physiol 1992;454:339-57.
42. Nayler WG. Calcium, ischemia, and the calcium antagonists. In: Godfraind T. ed. Calcium antagonists. The Netherlands: Kluwer Academic Publishers and Fondazione Giovanni Lorezini, 1993: 87-92.
43. Auchampach JA, Maruyama M, Cavero I, Gross G. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. J Pharmacol Exp Ther 1992;86:311-9.
44. Jones CE, Thomas JX, Parker JC, Parker RE. Acute changes in high-energy phosphates, nucleotide derivatives, and contractile force in ischaemic and nonischaemic canine myocardium following coronary occlusion. Cardiovasc Res 1976;10:275-82.
45. Jennings RB, Reimer KA, Hill ML, Mayer SE. Total ischemia in dog hearts in vitro. 1. Comparison of high-energy phosphate production, utilization and depletion and of adenine nucleotide catabolism in total ischemia in vitro vs. severe ischemia in vitro. Circ Res 1981;49:892-900.
46. Reimer DA, Hill ML, Jennings RB. Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs. J Mol Cell Cardiol 1981;13:229-39.
47. Swain JL, Sabina RL, Hines JJ, McHale PA, Greenfield JCJ, Holmes EW. Prolonged myocardial adenine nucleotide depletion after brief ischemia in the open-chest dog. Am J Physiol 1984;242: H818-26.
48. Hosoda H, Sunamori M, Watanabe M, Suzuki A. Effect of pinacidil combined with potassium cardioplegia on myocardial viability in hypothermie global ischemia. J Mol Cell Cardiol 1992;24(suppl I):S76.
49. Yao Z, Gross G. The ATP-dependent potassium channel: an endogenous cardioprotective mechanism. J Cardiovasc Pharmacol 1994:24(suppl 4):S28-34.
50. Grover GJ, Sleph PG. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemie rat myocardium with a lower functional cost as compared with verapamil or nifedipine. J Cardiovasc Pharmacol 1989;14:98-104.